首页 > 最新文献

Journal of the Turkish German Gynecological Association最新文献

英文 中文
Ovarian cancer and isolated cardiophrenic lymph nodes metastases: a systematic review. 卵巢癌和孤立的心性淋巴结转移:一项系统综述。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-12 DOI: 10.4274/jtgga.galenos.2024.2024-3-3
Victoria Psomiadou, Alexandros Fotiou, Christos Iavazzo

Currently, there is limited information available on the best course of action for advanced epithelial ovarian cancer (OC) with isolated extra-peritoneal disease in the cardiophrenic lymph nodes. Recently, there have been numerous reports of successful surgical removal of metastatic cardiophrenic lymph nodes in patients with OC, mostly during primary or interval cytoreduction procedures. However, the optimal management of isolated, extra-peritoneal cardiophrenic lymph node metastasis (ICLNM) remains unclear, since this clinical scenario is rather uncommon in OC and chemotherapy is so far the indicated treatment for patients with from advanced stage disease. We searched the English-language literature for cases of OC with ICLNM or recurrence, evaluating the feasibility and safety of surgical excision. From 2009 to 2022 only 11 cases were reported. In seven the tumor was of serous histology. ICLN was detected in five cases with primary disease and in the remaining six it was recurrence of OC. The primary disease was treated in 10/11 patients with primary cytoreduction while the other received systemic chemotherapy. The ICLNM was removed in all the patients, in 10 via video-assisted thoracic surgery and in one via transdiaphragmatic incision. Median follow-up was 10 months.

目前,关于晚期上皮性卵巢癌(OC)合并心房淋巴结孤立性腹膜外病变的最佳治疗方案的信息有限。最近,有许多报道成功手术切除转移性心性淋巴结的OC患者,主要是在原发性或间隔期细胞减少手术。然而,孤立的腹膜外心室性淋巴结转移(ICLNM)的最佳治疗方法仍不清楚,因为这种临床情况在OC中相当罕见,而化疗迄今为止是晚期疾病患者的适应症治疗。我们检索了英语文献中合并ICLNM或复发的OC病例,评估手术切除的可行性和安全性。从2009年到2022年,仅报告了11例病例。7例肿瘤呈浆液性组织学。在5例原发疾病中检测到ICLN,其余6例为卵巢癌复发。10/11例患者原发疾病采用原发细胞减少治疗,其余患者接受全身化疗。所有患者均切除了ICLNM,其中10例通过视频辅助胸外科手术,1例通过横膈膜切口。中位随访时间为10个月。
{"title":"Ovarian cancer and isolated cardiophrenic lymph nodes metastases: a systematic review.","authors":"Victoria Psomiadou, Alexandros Fotiou, Christos Iavazzo","doi":"10.4274/jtgga.galenos.2024.2024-3-3","DOIUrl":"10.4274/jtgga.galenos.2024.2024-3-3","url":null,"abstract":"<p><p>Currently, there is limited information available on the best course of action for advanced epithelial ovarian cancer (OC) with isolated extra-peritoneal disease in the cardiophrenic lymph nodes. Recently, there have been numerous reports of successful surgical removal of metastatic cardiophrenic lymph nodes in patients with OC, mostly during primary or interval cytoreduction procedures. However, the optimal management of isolated, extra-peritoneal cardiophrenic lymph node metastasis (ICLNM) remains unclear, since this clinical scenario is rather uncommon in OC and chemotherapy is so far the indicated treatment for patients with from advanced stage disease. We searched the English-language literature for cases of OC with ICLNM or recurrence, evaluating the feasibility and safety of surgical excision. From 2009 to 2022 only 11 cases were reported. In seven the tumor was of serous histology. ICLN was detected in five cases with primary disease and in the remaining six it was recurrence of OC. The primary disease was treated in 10/11 patients with primary cytoreduction while the other received systemic chemotherapy. The ICLNM was removed in all the patients, in 10 via video-assisted thoracic surgery and in one via transdiaphragmatic incision. Median follow-up was 10 months.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 1","pages":"49-54"},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pustular psoriasis of pregnancy with paradoxical facial involvement: an uncommon presentation-what is your diagnosis? 妊娠期脓疱性牛皮癣伴矛盾的面部累及:一种不常见的表现——你的诊断是什么?
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-12 DOI: 10.4274/jtgga.galenos.2024.2024-8-2
Deepthi Konda, Mishu Mangla, Thota Saisumanth, Seetu Palo, Naina Kumar
{"title":"Pustular psoriasis of pregnancy with paradoxical facial involvement: an uncommon presentation-what is your diagnosis?","authors":"Deepthi Konda, Mishu Mangla, Thota Saisumanth, Seetu Palo, Naina Kumar","doi":"10.4274/jtgga.galenos.2024.2024-8-2","DOIUrl":"10.4274/jtgga.galenos.2024.2024-8-2","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 1","pages":"62-64"},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the efficacy of injectable platelet-rich fibrin in genitourinary syndrome of menopause. 注射富血小板纤维蛋白治疗绝经期泌尿生殖系统综合征的疗效评价。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-12 DOI: 10.4274/jtgga.galenos.2024.2024-5-6
Pelin Oyardı, Ülkü Mete Ural

Objective: The aim of this study was to investigate the efficacy of injectable, platelet-rich fibrin (PRF) for the treatment of vaginal atrophy, also known as genitourinary syndrome of menopause (GSM), which may affect a third of a woman's lifespan.

Material and methods: This study included postmenopausal patients who had symptoms of genitourinary syndrome, such as vaginal burning, dryness, itching, and sexual dysfunction. Injectable platelet-rich fibrin (i-PRF) was applied to three areas on the posterior vaginal wall twice, one month apart. The genitourinary symptoms of the patients were evaluated using the female sexual function index (FSFI) and sexual life quality questionnaire before and one and six months after the procedure.

Results: Thirty-five patients were recruited with a mean age of 54.1±5.5 years. The analysis of the desire, arousal, lubrication, orgasm, satisfaction, pain, and total scores of the pre-procedural and post-procedural FSFI and sexual life quality questionnaire scores revealed significant improvements (p<0.001).

Conclusion: i-PRF treatment provided advantages such as safe and easy application, autologous material nature, absence of procedure-related complications or side effects, short procedure time, absence of the need for hospitalization, low cost, and a non-hormonal nature. These results suggest that injectable, PRF may be a promising treatment option in patients with symptoms of GSM. However, larger randomized controlled studies are needed to confirm and validate our findings.

目的:本研究的目的是研究可注射的富血小板纤维蛋白(PRF)治疗阴道萎缩的疗效,阴道萎缩也被称为绝经期泌尿生殖系统综合征(GSM),可能影响女性三分之一的寿命。材料和方法:本研究包括绝经后有泌尿生殖系统综合征症状的患者,如阴道灼烧、干燥、瘙痒和性功能障碍。将富血小板纤维蛋白(i-PRF)注射于阴道后壁三个部位两次,间隔一个月。术前、术后1个月和6个月分别采用女性性功能指数(FSFI)和性生活质量问卷对患者的泌尿生殖系统症状进行评价。结果:35例患者入组,平均年龄54.1±5.5岁。通过术前、术后FSFI评分和性生活质量问卷评分的性欲、性兴奋、润滑、性高潮、满意度、疼痛、总分的分析,均有明显改善(p结论:i-PRF治疗具有应用安全方便、材料本身、无手术相关并发症或副作用、手术时间短、无需住院、费用低、非激素性等优点。这些结果表明,可注射的PRF可能是有GSM症状的患者的一种有希望的治疗选择。然而,需要更大规模的随机对照研究来证实和验证我们的发现。
{"title":"Evaluation of the efficacy of injectable platelet-rich fibrin in genitourinary syndrome of menopause.","authors":"Pelin Oyardı, Ülkü Mete Ural","doi":"10.4274/jtgga.galenos.2024.2024-5-6","DOIUrl":"10.4274/jtgga.galenos.2024.2024-5-6","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate the efficacy of injectable, platelet-rich fibrin (PRF) for the treatment of vaginal atrophy, also known as genitourinary syndrome of menopause (GSM), which may affect a third of a woman's lifespan.</p><p><strong>Material and methods: </strong>This study included postmenopausal patients who had symptoms of genitourinary syndrome, such as vaginal burning, dryness, itching, and sexual dysfunction. Injectable platelet-rich fibrin (i-PRF) was applied to three areas on the posterior vaginal wall twice, one month apart. The genitourinary symptoms of the patients were evaluated using the female sexual function index (FSFI) and sexual life quality questionnaire before and one and six months after the procedure.</p><p><strong>Results: </strong>Thirty-five patients were recruited with a mean age of 54.1±5.5 years. The analysis of the desire, arousal, lubrication, orgasm, satisfaction, pain, and total scores of the pre-procedural and post-procedural FSFI and sexual life quality questionnaire scores revealed significant improvements (p<0.001).</p><p><strong>Conclusion: </strong>i-PRF treatment provided advantages such as safe and easy application, autologous material nature, absence of procedure-related complications or side effects, short procedure time, absence of the need for hospitalization, low cost, and a non-hormonal nature. These results suggest that injectable, PRF may be a promising treatment option in patients with symptoms of GSM. However, larger randomized controlled studies are needed to confirm and validate our findings.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 1","pages":"15-19"},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral health protection and restorative approaches in the puerperal period. 产褥期口腔健康保护及修复方法。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-03-12 DOI: 10.4274/jtgga.galenos.2025.2024-6-9
Zeynep Yenen, Müfit Yenen

There is a growing need for dental treatments in women during the puerperal period as a consequence of hormonal and physiological changes that occur. There are effective methods that dentists can apply while treating patients in the puerperal period and while ensuring the maintenance of treatment. The framework of these methods covers a wide range of subjects, from the examination and diagnosis process of the dentist to the treatment protocols and the oral hygiene motivation of the patient. This review focuses on restorative treatment protocols that dentists would apply to patients in the puerperal period and the maintenance of these treatments.

由于发生激素和生理变化,在产褥期的妇女越来越需要牙科治疗。牙医在治疗产褥期的病人时,可以采用一些有效的方法,同时确保治疗的维持。这些方法的框架涵盖了广泛的主题,从牙医的检查和诊断过程到治疗方案和患者的口腔卫生动机。本文综述了牙医对产褥期患者的恢复性治疗方案以及这些治疗的维持。
{"title":"Oral health protection and restorative approaches in the puerperal period.","authors":"Zeynep Yenen, Müfit Yenen","doi":"10.4274/jtgga.galenos.2025.2024-6-9","DOIUrl":"10.4274/jtgga.galenos.2025.2024-6-9","url":null,"abstract":"<p><p>There is a growing need for dental treatments in women during the puerperal period as a consequence of hormonal and physiological changes that occur. There are effective methods that dentists can apply while treating patients in the puerperal period and while ensuring the maintenance of treatment. The framework of these methods covers a wide range of subjects, from the examination and diagnosis process of the dentist to the treatment protocols and the oral hygiene motivation of the patient. This review focuses on restorative treatment protocols that dentists would apply to patients in the puerperal period and the maintenance of these treatments.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 1","pages":"55-61"},"PeriodicalIF":1.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143615830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of first trimester maternal fat tissue measurement in prediction of gestational diabetes: a prospective cohort study 前三个月孕妇脂肪组织测量对预测妊娠糖尿病的有效性:一项前瞻性队列研究。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 Epub Date: 2024-09-10 DOI: 10.4274/jtgga.galenos.2023.2023-4-6
Cağdaş Nurettin Emeklioğlu, Hicran Acar Şirinoğlu, Miraç Özalp, Melike Eren, Elif Akkoç Demirel, Simten Genç, Veli Mihmanlı

Objective: The aim was to find a cost-effective, more practical method to be used in the early gestational weeks as an alternative to the oral glucose tolerance test (OGTT) for predicting gestational diabetes mellitus (GDM). The method selected was adipose tissue measurements made in the first trimester.

Material and methods: The study was designed as a prospective, cohort study. Ultrasound images were used to calculate abdominal visceral (VAT) and subcutaneous adipose tissue (SAT) thicknesses of the first trimester pregnant women. Two groups were formed: those who were diagnosed with GDM and those who were not, based on the results of the OGTT performed in the same patients at 24th-28th weeks of gestation. Ultrasonographic records were examined and compared between these two groups using received operator characteristic curves and logistic regression analyses.

Results: A total of 292 pregnant women were included, of whom 21.2% were diagnosed with GDM. In the group diagnosed with GDM, SAT, VAT and total adipose tissue (TAT) values were significantly higher than the women who did not have GDM. Threshold values for SAT, VAT and TAT were 18 mm, 55 mm and 55 mm.

Conclusion: First trimester SAT, VAT and TAT measurements of pregnant women with GDM were significantly higher than those without GDM diagnosis. Although our results showed that adipose measurements cannot be an alternative to OGTT; they may be a powerful aid in identify at-risk pregnant women, suggesting to perform an early OGTT in the first trimester.

目的:目的是寻找一种成本效益高、更实用的方法,用于在妊娠早期替代口服葡萄糖耐量试验(OGTT)预测妊娠糖尿病(GDM)。所选方法是在妊娠头三个月测量脂肪组织:该研究是一项前瞻性队列研究。使用超声波图像计算怀孕头三个月孕妇的腹部内脏脂肪组织(VAT)和皮下脂肪组织(SAT)厚度。根据同一患者在妊娠 24-28 周时进行的 OGTT 结果,将其分为两组:被确诊为 GDM 的孕妇和未被确诊为 GDM 的孕妇。通过接收操作者特征曲线和逻辑回归分析,对这两组患者的超声波记录进行了检查和比较:结果:共纳入 292 名孕妇,其中 21.2% 被诊断为 GDM。在确诊为 GDM 的孕妇组中,SAT、VAT 和总脂肪组织(TAT)值明显高于未确诊为 GDM 的孕妇。SAT、VAT 和 TAT 的阈值分别为 18 毫米、55 毫米和 55 毫米:结论:患有 GDM 的孕妇在怀孕头三个月的 SAT、VAT 和 TAT 测量值明显高于未确诊 GDM 的孕妇。虽然我们的结果表明脂肪测量不能替代 OGTT,但它们可能是识别高危孕妇的有力辅助工具,建议在妊娠头三个月及早进行 OGTT。
{"title":"Effectiveness of first trimester maternal fat tissue measurement in prediction of gestational diabetes: a prospective cohort study","authors":"Cağdaş Nurettin Emeklioğlu, Hicran Acar Şirinoğlu, Miraç Özalp, Melike Eren, Elif Akkoç Demirel, Simten Genç, Veli Mihmanlı","doi":"10.4274/jtgga.galenos.2023.2023-4-6","DOIUrl":"10.4274/jtgga.galenos.2023.2023-4-6","url":null,"abstract":"<p><strong>Objective: </strong>The aim was to find a cost-effective, more practical method to be used in the early gestational weeks as an alternative to the oral glucose tolerance test (OGTT) for predicting gestational diabetes mellitus (GDM). The method selected was adipose tissue measurements made in the first trimester.</p><p><strong>Material and methods: </strong>The study was designed as a prospective, cohort study. Ultrasound images were used to calculate abdominal visceral (VAT) and subcutaneous adipose tissue (SAT) thicknesses of the first trimester pregnant women. Two groups were formed: those who were diagnosed with GDM and those who were not, based on the results of the OGTT performed in the same patients at 24<sup>th</sup>-28<sup>th</sup> weeks of gestation. Ultrasonographic records were examined and compared between these two groups using received operator characteristic curves and logistic regression analyses.</p><p><strong>Results: </strong>A total of 292 pregnant women were included, of whom 21.2% were diagnosed with GDM. In the group diagnosed with GDM, SAT, VAT and total adipose tissue (TAT) values were significantly higher than the women who did not have GDM. Threshold values for SAT, VAT and TAT were 18 mm, 55 mm and 55 mm.</p><p><strong>Conclusion: </strong>First trimester SAT, VAT and TAT measurements of pregnant women with GDM were significantly higher than those without GDM diagnosis. Although our results showed that adipose measurements cannot be an alternative to OGTT; they may be a powerful aid in identify at-risk pregnant women, suggesting to perform an early OGTT in the first trimester.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"224-230"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142290007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome. 基础血清黄体生成素、总睾酮和游离睾酮水平不影响多囊卵巢综合征患者的体外受精结果。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 DOI: 10.4274/jtgga.galenos.2024.2024-2-9
Nir Kugelman, Alyson Digby, Keren Rotshenker-Olshinka, Véronique Bellemare, Amrita Pooni, Weon-Young Son, Michael H Dahan

Objective: To assess the influence of basal serum levels of luteinizing hormone (LH), total testosterone (TT), and free testosterone (FT) on in vitro fertilization (IVF) success rates in patients with polycystic ovary syndrome (PCOS).

Material and methods: A retrospective cohort analysis of PCOS patients who underwent freeze-all, gonadotropin releasing hormone (GnRH) antagonist IVF protocols from January 2013 to December 2019. Patients were grouped based on median basal serum levels of LH, TT, and FT to compare their IVF outcomes.

Results: A total of 76 women with PCOS diagnosed as per the 2003 Rotterdam criteria were included. When analyzed by LH levels, groups had similar baseline characteristics except for higher mean ± standard deviation TT (1.4±0.9 vs. 1.9±0.9 nmol/L, p=0.02) and FT (0.6±0.5 vs. 0.9±0.5 nmol/L, p=0.03) in the elevated LH group. However, clinical pregnancy rates (CPR) (34.2% vs. 44.7%, p=0.35) and live birth rates (LBR) (21.0% vs. 31.6%, p=0.29) were not different. The group with lower TT had more previous pregnancies (0.9±1.2 vs. 0.3±0.7, p=0.02) and shorter infertility duration (2.3±2.0 vs. 3.7±2.7 years, p=0.04), but again CPR (46.8% vs. 42.8%, p=0.90) and LBR (37.5% vs. 25.7%, p=0.33) were similar. FT analysis revealed no significant differences in CPR (48.2% vs. 36.7%, p=0.36) and LBR (23.2% vs. 37.9%, p=0.22) despite higher TT (1.1±0.4 vs. 2.2±1.1 nmol/L, p<0.001) and LH (6.1±3.8 vs. 11.2±7.2 IU/L, p<0.001) in the high FT group.

Conclusion: Basal serum levels of LH, TT, and FT did not significantly affect IVF outcomes in patients with PCOS using GnRH antagonist, freeze-all protocols.

目的:探讨血清黄体生成素(LH)、总睾酮(TT)和游离睾酮(FT)水平对多囊卵巢综合征(PCOS)患者体外受精(IVF)成功率的影响。材料和方法:对2013年1月至2019年12月接受冷冻全促性腺激素释放激素(GnRH)拮抗剂体外受精方案的PCOS患者进行回顾性队列分析。根据LH、TT和FT的中位基础血清水平对患者进行分组,比较他们的IVF结果。结果:共纳入76例经2003年鹿特丹标准诊断为多囊卵巢综合征的妇女。当LH水平分析时,各组基线特征相似,除了LH升高组的平均±标准差TT(1.4±0.9 vs 1.9±0.9 nmol/L, p=0.02)和FT(0.6±0.5 vs 0.9±0.5 nmol/L, p=0.03)更高。然而,临床妊娠率(CPR)(34.2%比44.7%,p=0.35)和活产率(LBR)(21.0%比31.6%,p=0.29)无差异。TT较低组妊娠史较多(0.9±1.2比0.3±0.7,p=0.02),不孕症持续时间较短(2.3±2.0比3.7±2.7年,p=0.04),但CPR(46.8%比42.8%,p=0.90)和LBR(37.5%比25.7%,p=0.33)相似。尽管TT较高(1.1±0.4 vs 2.2±1.1 nmol/L),但FT分析显示CPR (48.2% vs 36.7%, p=0.36)和LBR (23.2% vs 37.9%, p=0.22)无显著差异。结论:基础血清LH、TT和FT水平对使用GnRH拮抗剂的PCOS患者体外受精结果无显著影响。
{"title":"Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome.","authors":"Nir Kugelman, Alyson Digby, Keren Rotshenker-Olshinka, Véronique Bellemare, Amrita Pooni, Weon-Young Son, Michael H Dahan","doi":"10.4274/jtgga.galenos.2024.2024-2-9","DOIUrl":"10.4274/jtgga.galenos.2024.2024-2-9","url":null,"abstract":"<p><strong>Objective: </strong>To assess the influence of basal serum levels of luteinizing hormone (LH), total testosterone (TT), and free testosterone (FT) on in vitro fertilization (IVF) success rates in patients with polycystic ovary syndrome (PCOS).</p><p><strong>Material and methods: </strong>A retrospective cohort analysis of PCOS patients who underwent freeze-all, gonadotropin releasing hormone (GnRH) antagonist IVF protocols from January 2013 to December 2019. Patients were grouped based on median basal serum levels of LH, TT, and FT to compare their IVF outcomes.</p><p><strong>Results: </strong>A total of 76 women with PCOS diagnosed as per the 2003 Rotterdam criteria were included. When analyzed by LH levels, groups had similar baseline characteristics except for higher mean ± standard deviation TT (1.4±0.9 vs. 1.9±0.9 nmol/L, p=0.02) and FT (0.6±0.5 vs. 0.9±0.5 nmol/L, p=0.03) in the elevated LH group. However, clinical pregnancy rates (CPR) (34.2% vs. 44.7%, p=0.35) and live birth rates (LBR) (21.0% vs. 31.6%, p=0.29) were not different. The group with lower TT had more previous pregnancies (0.9±1.2 vs. 0.3±0.7, p=0.02) and shorter infertility duration (2.3±2.0 vs. 3.7±2.7 years, p=0.04), but again CPR (46.8% vs. 42.8%, p=0.90) and LBR (37.5% vs. 25.7%, p=0.33) were similar. FT analysis revealed no significant differences in CPR (48.2% vs. 36.7%, p=0.36) and LBR (23.2% vs. 37.9%, p=0.22) despite higher TT (1.1±0.4 vs. 2.2±1.1 nmol/L, p<0.001) and LH (6.1±3.8 vs. 11.2±7.2 IU/L, p<0.001) in the high FT group.</p><p><strong>Conclusion: </strong>Basal serum levels of LH, TT, and FT did not significantly affect IVF outcomes in patients with PCOS using GnRH antagonist, freeze-all protocols.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"25 4","pages":"192-199"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is your diagnosis? 你的诊断是什么?
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 DOI: 10.4274/jtgga.galenos.2024.2024-4-3
Anupama Bahadur, Rajlaxmi Mundhra, Ayush Heda, Shalinee Rao, Gupchee Singh, Shriram Rundla, Sakshi Heda
{"title":"What is your diagnosis?","authors":"Anupama Bahadur, Rajlaxmi Mundhra, Ayush Heda, Shalinee Rao, Gupchee Singh, Shriram Rundla, Sakshi Heda","doi":"10.4274/jtgga.galenos.2024.2024-4-3","DOIUrl":"10.4274/jtgga.galenos.2024.2024-4-3","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"25 4","pages":"266-269"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new technique for stress urinary incontinence without using vaginal mesh. 不使用阴道补片治疗压力性尿失禁的新技术。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 DOI: 10.4274/jtgga.galenos.2023.2022-12-17
Emin Erhan Dönmez, Mustafa Oğuzhan Kılıç, Fisun Vural

Stress urinary incontinence (SUI) is a fairly common disease among women. Synthetic meshes are frequently used in midurethral sling procedures due to the high long-term success rates. Because of the publications about vaginal mesh complications in recent years, urogynecologists are turning to techniques without mesh. The purpose of this video is to show that SUI can be treated without mesh complications by utilizing the meshless urethropexy technique. A 50-year-old woman applied to our urogynecology department with complaints of incontinence. Physical examination, stress test, Q-tip test, urine test and transperineal ultrasound performed. Post-void residual urine measured. The patient completed incontinence questionnaires: urogenital distress inventory-6, incontinence impact questionnaire-7. After discussing results SUI was diagnosed. Treatment options were offered to the patient. Due to mesh complications concern the patient preferred this approach and underwent urethropexy. The steps of meshless urethropexy technique was demonstrated in this video. SUI can be treated with this approach without worrying about mesh complications, but long-term results are needed.

压力性尿失禁(SUI)是一种相当常见的女性疾病。由于长期成功率高,合成网经常用于尿道中悬吊手术。由于近年来关于阴道补片并发症的出版物,泌尿妇科医生正在转向无补片技术。本视频的目的是展示利用无网状输尿管固定术治疗SUI可无网状并发症。一名50岁女性以尿失禁主诉到泌尿妇科就诊。体检、压力测试、棉签测试、尿检、会阴超声检查。测量空后残尿。患者完成尿失禁问卷:泌尿生殖窘迫问卷-6,尿失禁影响问卷-7。经讨论结果诊断为SUI。向患者提供了治疗方案。由于担心补片并发症,患者选择了这种方法并接受了尿道固定术。本视频演示了无网格尿道固定术的步骤。SUI可以用这种方法治疗而不用担心补片并发症,但需要长期的结果。
{"title":"A new technique for stress urinary incontinence without using vaginal mesh.","authors":"Emin Erhan Dönmez, Mustafa Oğuzhan Kılıç, Fisun Vural","doi":"10.4274/jtgga.galenos.2023.2022-12-17","DOIUrl":"10.4274/jtgga.galenos.2023.2022-12-17","url":null,"abstract":"<p><p>Stress urinary incontinence (SUI) is a fairly common disease among women. Synthetic meshes are frequently used in midurethral sling procedures due to the high long-term success rates. Because of the publications about vaginal mesh complications in recent years, urogynecologists are turning to techniques without mesh. The purpose of this video is to show that SUI can be treated without mesh complications by utilizing the meshless urethropexy technique. A 50-year-old woman applied to our urogynecology department with complaints of incontinence. Physical examination, stress test, Q-tip test, urine test and transperineal ultrasound performed. Post-void residual urine measured. The patient completed incontinence questionnaires: urogenital distress inventory-6, incontinence impact questionnaire-7. After discussing results SUI was diagnosed. Treatment options were offered to the patient. Due to mesh complications concern the patient preferred this approach and underwent urethropexy. The steps of meshless urethropexy technique was demonstrated in this video. SUI can be treated with this approach without worrying about mesh complications, but long-term results are needed.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"25 4","pages":"277-279"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specialist and general emergency room: from "A to Z" case series of possible misdiagnosis due to the influence of gender. 专科和普通急诊室:从“A到Z”病例系列可能因性别影响而误诊。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 DOI: 10.4274/jtgga.galenos.2024.2024-12-6
Paola Algeri, Maria Donata Spazzini, Nina Pinna
{"title":"Specialist and general emergency room: from \"A to Z\" case series of possible misdiagnosis due to the influence of gender.","authors":"Paola Algeri, Maria Donata Spazzini, Nina Pinna","doi":"10.4274/jtgga.galenos.2024.2024-12-6","DOIUrl":"10.4274/jtgga.galenos.2024.2024-12-6","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"25 4","pages":"270-272"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second-trimester spontaneous uterine rupture: a rare case of diagnostic nuances and multidisciplinary management 妊娠中期自发性子宫破裂:一个罕见的病例诊断的细微差别和多学科管理。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-10 Epub Date: 2024-12-09 DOI: 10.4274/jtgga.galenos.2024.2024-10-3
Celine Sooknarine, Esra Çetin, David H Pyatt Ii, Koray Görkem Saçıntı, Atinuke L Akinpeloye
{"title":"Second-trimester spontaneous uterine rupture: a rare case of diagnostic nuances and multidisciplinary management","authors":"Celine Sooknarine, Esra Çetin, David H Pyatt Ii, Koray Görkem Saçıntı, Atinuke L Akinpeloye","doi":"10.4274/jtgga.galenos.2024.2024-10-3","DOIUrl":"10.4274/jtgga.galenos.2024.2024-10-3","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"273-276"},"PeriodicalIF":1.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Turkish German Gynecological Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1